CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 45 filers reported holding CASI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $65,000 | +32.7% | 26,000 | +8.3% | 0.01% | +28.6% |
| Q1 2020 | $49,000 | -47.3% | 24,000 | -20.0% | 0.01% | -36.4% |
| Q4 2019 | $93,000 | -7.0% | 30,000 | 0.0% | 0.01% | -21.4% |
| Q3 2019 | $100,000 | +4.2% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $96,000 | +17.1% | 30,000 | +4.4% | 0.01% | 0.0% |
| Q1 2019 | $82,000 | -13.7% | 28,725 | +21.1% | 0.01% | -22.2% |
| Q4 2018 | $95,000 | +90.0% | 23,725 | +121.2% | 0.02% | +63.6% |
| Q3 2018 | $50,000 | +66.7% | 10,725 | +53.2% | 0.01% | +37.5% |
| Q1 2018 | $30,000 | +20.0% | 7,000 | 0.0% | 0.01% | +14.3% |
| Q4 2017 | $25,000 | – | 7,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |